Integrating Addiction Treatment and HIV Services Into Primary Care Clinics in Ukraine
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,458
- 试验地点
- 1
- 主要终点
- Average percentage of recommended Quality Health Indicator services accessed by participants to assess efficacy
研究概览
简要总结
A randomized controlled trial to:
- To compare both primary (composite quality health indicator (QHI) scores) and secondary (individual HIV/methadone maintenance treatment (MMT)/TB/primary care QHI scores, quality of life, and stigma) outcomes in an anticipated 1,350 people who inject drugs (PWID) receiving MMT from 13 regions (clusters) and 39 clinical settings using a stratified, phase-in, controlled design over 24 months. After stratifying PWIDs based on their current receipt of MMT, they will be randomized to receive MMT in specialty addiction clinics (N=450) or in an ECHO-IC/QI-enhanced primary care clinic with (N=450) or without (N=450) pay for performance (P4P) incentives.
- Using a multi-level implementation science framework, to examine the contribution of client, clinician and organizational factors that contribute to the comprehensive composite (primary outcome) and individual (secondary) QHI scores.
详细描述
Original outcomes were edited and Implementation outcomes were added November 2023.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Interested in MMT
- •Meets DSM-V criteria for Opioid Dependence
排除标准
- •Not willing to consent
结局指标
主要结局
Average percentage of recommended Quality Health Indicator services accessed by participants to assess efficacy
时间窗: every 6 months up to 24 months
The total average percentage of the 17 recommended Quality Health Indicator screenings and services that were accessed by participants to assess efficacy. Recommended QHI screenings are as follows: General medical examination; blood analysis; urine analysis; cardiogram; mammogram; cervical cancer screening; prostate cancer screening; hepatitis B screening; hepatitis C screening; HIV screening; CD4 or viral load; ART treatment; TB screening; TB treatment; received take-home MMT; adequate MMT dose; on MMT for 12 months.
次要结局
- Average percentage of recommended HIV Quality Health Indicator services accessed to assess efficacy(every 6 months up to 24 months)
- Average percentage of recommended MMT Quality Health Indicator services accessed to assess efficacy(every 6 months up to 24 months)
- Average percentage of recommended TB Quality Health Indicator services accessed to assess efficacy(every 6 months up to 24 months)